Imunon: A New Hope in Ovarian Cancer Treatment
Welcome to Biotech Spotlight, where we talk about companies creating groundbreaking technologies and products. Today, we’re discussing Imunon, a company […]
New Findings Show Long-Term Benefits of Lecanemab for Alzheimer’s Patients
Eisai, a pharmaceutical company, has shared new clinical data from a study called Clarity AD. This study looked at adults
Bristol Myers Squibb and Johnson & Johnson Pause a Study on New Blood Thinner Drug
Two big drug companies, Bristol Myers Squibb and Johnson & Johnson, have stopped a major study on a new experimental
Big Pharma MSD Buys Cidara for $9.2bn to Boost Infectious Disease Drugs
MSD, a large pharmaceutical company, has agreed to buy Cidara Therapeutics for $9.2 billion. This deal will add a new
Evotec and Bristol Myers Squibb Reach Important Milestone in Drug Development
Evotec, a biopharmaceutical company based in Hamburg, Germany, has received a $5 million payment from Bristol Myers Squibb. This payment
Mangoceuticals’ Stock Drops After Drugmakers Deny Partnership
Mangoceuticals, a company that sells medicines online, said it had teamed up with drugmakers Eli Lilly and Novo Nordisk to
FDA Approves Johnson & Johnson’s Darzalex Faspro for Early-Stage Multiple Myeloma
Johnson & Johnson’s cancer drug, Darzalex Faspro, has been approved by the FDA for use in a very early stage
Pharmaceutical News
New Method for Making Medicines Could Be a Game Changer
Researchers have found a simple way to start chemical reactions that could help make small molecule drugs. This could be
Johnson & Johnson’s New Drug Approved for Severe Depression
Johnson & Johnson has received approval from the Food and Drug Administration (FDA) to sell its drug Caplyta for treating
New Hope for Multiple Myeloma Patients: HDP-101 Shows Promising Results
Heidelberg Pharma has shared good news about their HDP-101 treatment for multiple myeloma, a type of blood cancer. This treatment